Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs1061622

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr1:12192898 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
T>G
Variation Type
SNV Single Nucleotide Variation
Frequency
G=0.208451 (55175/264690, TOPMED)
G=0.216294 (54148/250344, GnomAD_exome)
G=0.232235 (55035/236980, ALFA) (+ 27 more)
G=0.216252 (30287/140054, GnomAD)
G=0.224865 (26987/120014, ExAC)
G=0.18246 (14359/78696, PAGE_STUDY)
G=0.12287 (3472/28258, 14KJPN)
G=0.12154 (2037/16760, 8.3KJPN)
G=0.23051 (2998/13006, GO-ESP)
G=0.1907 (1221/6404, 1000G_30x)
G=0.1947 (975/5008, 1000G)
G=0.2397 (1074/4480, Estonian)
G=0.2392 (922/3854, ALSPAC)
G=0.2411 (894/3708, TWINSUK)
G=0.0996 (327/3284, PRJNA289433)
G=0.1663 (487/2928, KOREAN)
G=0.1943 (405/2084, HGDP_Stanford)
G=0.2061 (390/1892, HapMap)
G=0.1719 (315/1832, Korea1K)
G=0.225 (225/998, GoNL)
G=0.216 (166/768, PRJEB37584)
G=0.217 (130/600, NorthernSweden)
G=0.150 (80/534, MGP)
G=0.222 (64/288, FINRISK)
G=0.255 (55/216, Qatari)
G=0.108 (23/212, Vietnamese)
T=0.407 (74/182, SGDP_PRJ)
G=0.11 (10/92, Ancient Sardinia)
G=0.38 (15/40, GENOME_DK)
T=0.35 (7/20, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
TNFRSF1B : Missense Variant
Publications
60 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20230706150541
Population Group Sample Size Ref Allele Alt Allele
Total Global 253198 T=0.768541 G=0.231459
European Sub 215208 T=0.765980 G=0.234020
African Sub 12950 T=0.79444 G=0.20556
African Others Sub 456 T=0.849 G=0.151
African American Sub 12494 T=0.79246 G=0.20754
Asian Sub 786 T=0.838 G=0.162
East Asian Sub 612 T=0.851 G=0.149
Other Asian Sub 174 T=0.793 G=0.207
Latin American 1 Sub 1126 T=0.8126 G=0.1874
Latin American 2 Sub 2854 T=0.8532 G=0.1468
South Asian Sub 5048 T=0.7393 G=0.2607
Other Sub 15226 T=0.76967 G=0.23033


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 T=0.791549 G=0.208451
gnomAD - Exomes Global Study-wide 250344 T=0.783706 G=0.216294
gnomAD - Exomes European Sub 134504 T=0.764334 G=0.235666
gnomAD - Exomes Asian Sub 48968 T=0.77773 G=0.22227
gnomAD - Exomes American Sub 34540 T=0.88034 G=0.11966
gnomAD - Exomes African Sub 16166 T=0.79197 G=0.20803
gnomAD - Exomes Ashkenazi Jewish Sub 10050 T=0.73134 G=0.26866
gnomAD - Exomes Other Sub 6116 T=0.7760 G=0.2240
Allele Frequency Aggregator Total Global 236980 T=0.767765 G=0.232235
Allele Frequency Aggregator European Sub 205238 T=0.765813 G=0.234187
Allele Frequency Aggregator Other Sub 13798 T=0.76960 G=0.23040
Allele Frequency Aggregator African Sub 8130 T=0.7886 G=0.2114
Allele Frequency Aggregator South Asian Sub 5048 T=0.7393 G=0.2607
Allele Frequency Aggregator Latin American 2 Sub 2854 T=0.8532 G=0.1468
Allele Frequency Aggregator Latin American 1 Sub 1126 T=0.8126 G=0.1874
Allele Frequency Aggregator Asian Sub 786 T=0.838 G=0.162
gnomAD - Genomes Global Study-wide 140054 T=0.783748 G=0.216252
gnomAD - Genomes European Sub 75858 T=0.76469 G=0.23531
gnomAD - Genomes African Sub 41956 T=0.79512 G=0.20488
gnomAD - Genomes American Sub 13650 T=0.84857 G=0.15143
gnomAD - Genomes Ashkenazi Jewish Sub 3316 T=0.7337 G=0.2663
gnomAD - Genomes East Asian Sub 3128 T=0.8430 G=0.1570
gnomAD - Genomes Other Sub 2146 T=0.8136 G=0.1864
ExAC Global Study-wide 120014 T=0.775135 G=0.224865
ExAC Europe Sub 72360 T=0.75560 G=0.24440
ExAC Asian Sub 25028 T=0.77433 G=0.22567
ExAC American Sub 11470 T=0.88291 G=0.11709
ExAC African Sub 10266 T=0.79515 G=0.20485
ExAC Other Sub 890 T=0.766 G=0.234
The PAGE Study Global Study-wide 78696 T=0.81754 G=0.18246
The PAGE Study AfricanAmerican Sub 32514 T=0.79031 G=0.20969
The PAGE Study Mexican Sub 10810 T=0.86531 G=0.13469
The PAGE Study Asian Sub 8318 T=0.8609 G=0.1391
The PAGE Study PuertoRican Sub 7918 T=0.8443 G=0.1557
The PAGE Study NativeHawaiian Sub 4534 T=0.7739 G=0.2261
The PAGE Study Cuban Sub 4228 T=0.7904 G=0.2096
The PAGE Study Dominican Sub 3828 T=0.8090 G=0.1910
The PAGE Study CentralAmerican Sub 2450 T=0.8608 G=0.1392
The PAGE Study SouthAmerican Sub 1980 T=0.8692 G=0.1308
The PAGE Study NativeAmerican Sub 1260 T=0.7968 G=0.2032
The PAGE Study SouthAsian Sub 856 T=0.770 G=0.230
14KJPN JAPANESE Study-wide 28258 T=0.87713 G=0.12287
8.3KJPN JAPANESE Study-wide 16760 T=0.87846 G=0.12154
GO Exome Sequencing Project Global Study-wide 13006 T=0.76949 G=0.23051
GO Exome Sequencing Project European American Sub 8600 T=0.7594 G=0.2406
GO Exome Sequencing Project African American Sub 4406 T=0.7892 G=0.2108
1000Genomes_30x Global Study-wide 6404 T=0.8093 G=0.1907
1000Genomes_30x African Sub 1786 T=0.8236 G=0.1764
1000Genomes_30x Europe Sub 1266 T=0.7788 G=0.2212
1000Genomes_30x South Asian Sub 1202 T=0.7304 G=0.2696
1000Genomes_30x East Asian Sub 1170 T=0.8547 G=0.1453
1000Genomes_30x American Sub 980 T=0.865 G=0.135
1000Genomes Global Study-wide 5008 T=0.8053 G=0.1947
1000Genomes African Sub 1322 T=0.8132 G=0.1868
1000Genomes East Asian Sub 1008 T=0.8502 G=0.1498
1000Genomes Europe Sub 1006 T=0.7823 G=0.2177
1000Genomes South Asian Sub 978 T=0.724 G=0.276
1000Genomes American Sub 694 T=0.873 G=0.127
Genetic variation in the Estonian population Estonian Study-wide 4480 T=0.7603 G=0.2397
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 T=0.7608 G=0.2392
UK 10K study - Twins TWIN COHORT Study-wide 3708 T=0.7589 G=0.2411
MxGDAR/Encodat-PGx Global Study-wide 3284 T=0.9004 G=0.0996
MxGDAR/Encodat-PGx MxGDAR Sub 3284 T=0.9004 G=0.0996
KOREAN population from KRGDB KOREAN Study-wide 2928 T=0.8337 G=0.1663
HGDP-CEPH-db Supplement 1 Global Study-wide 2084 T=0.8057 G=0.1943
HGDP-CEPH-db Supplement 1 Est_Asia Sub 470 T=0.851 G=0.149
HGDP-CEPH-db Supplement 1 Central_South_Asia Sub 414 T=0.763 G=0.237
HGDP-CEPH-db Supplement 1 Middle_Est Sub 350 T=0.723 G=0.277
HGDP-CEPH-db Supplement 1 Europe Sub 320 T=0.791 G=0.209
HGDP-CEPH-db Supplement 1 Africa Sub 242 T=0.740 G=0.260
HGDP-CEPH-db Supplement 1 America Sub 216 T=0.972 G=0.028
HGDP-CEPH-db Supplement 1 Oceania Sub 72 T=0.94 G=0.06
HapMap Global Study-wide 1892 T=0.7939 G=0.2061
HapMap American Sub 770 T=0.779 G=0.221
HapMap African Sub 692 T=0.790 G=0.210
HapMap Asian Sub 254 T=0.843 G=0.157
HapMap Europe Sub 176 T=0.801 G=0.199
Korean Genome Project KOREAN Study-wide 1832 T=0.8281 G=0.1719
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 T=0.775 G=0.225
CNV burdens in cranial meningiomas Global Study-wide 768 T=0.784 G=0.216
CNV burdens in cranial meningiomas CRM Sub 768 T=0.784 G=0.216
Northern Sweden ACPOP Study-wide 600 T=0.783 G=0.217
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 T=0.850 G=0.150
FINRISK Finnish from FINRISK project Study-wide 288 T=0.778 G=0.222
Qatari Global Study-wide 216 T=0.745 G=0.255
A Vietnamese Genetic Variation Database Global Study-wide 212 T=0.892 G=0.108
SGDP_PRJ Global Study-wide 182 T=0.407 G=0.593
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 92 T=0.89 G=0.11
The Danish reference pan genome Danish Study-wide 40 T=0.62 G=0.38
Siberian Global Study-wide 20 T=0.35 G=0.65
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 1 NC_000001.11:g.12192898T>G
GRCh37.p13 chr 1 NC_000001.10:g.12252955T>G
TNFRSF1B RefSeqGene NG_029791.1:g.30896T>G
Gene: TNFRSF1B, TNF receptor superfamily member 1B (plus strand)
Molecule type Change Amino acid[Codon] SO Term
TNFRSF1B transcript NM_001066.3:c.587T>G M [ATG] > R [AGG] Coding Sequence Variant
tumor necrosis factor receptor superfamily member 1B precursor NP_001057.1:p.Met196Arg M (Met) > R (Arg) Missense Variant
TNFRSF1B transcript variant X1 XM_011542060.3:c.587T>G M [ATG] > R [AGG] Coding Sequence Variant
tumor necrosis factor receptor superfamily member 1B isoform X1 XP_011540362.1:p.Met196Arg M (Met) > R (Arg) Missense Variant
TNFRSF1B transcript variant X2 XM_047429422.1:c.587T>G M [ATG] > R [AGG] Coding Sequence Variant
tumor necrosis factor receptor superfamily member 1B isoform X2 XP_047285378.1:p.Met196Arg M (Met) > R (Arg) Missense Variant
TNFRSF1B transcript variant X3 XM_047429423.1:c.566T>G M [ATG] > R [AGG] Coding Sequence Variant
tumor necrosis factor receptor superfamily member 1B isoform X3 XP_047285379.1:p.Met189Arg M (Met) > R (Arg) Missense Variant
TNFRSF1B transcript variant X4 XM_011542063.3:c.587T>G M [ATG] > R [AGG] Coding Sequence Variant
tumor necrosis factor receptor superfamily member 1B isoform X4 XP_011540365.1:p.Met196Arg M (Met) > R (Arg) Missense Variant
TNFRSF1B transcript variant X5 XM_047429424.1:c.434T>G M [ATG] > R [AGG] Coding Sequence Variant
tumor necrosis factor receptor superfamily member 1B isoform X5 XP_047285380.1:p.Met145Arg M (Met) > R (Arg) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: G (allele ID: 1036917 )
ClinVar Accession Disease Names Clinical Significance
RCV001354054.1 Susceptibility to severe coronavirus disease (COVID-19) Uncertain-Significance
RCV001836993.1 Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR2 Uncertain-Significance
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement T= G
GRCh38.p14 chr 1 NC_000001.11:g.12192898= NC_000001.11:g.12192898T>G
GRCh37.p13 chr 1 NC_000001.10:g.12252955= NC_000001.10:g.12252955T>G
TNFRSF1B RefSeqGene NG_029791.1:g.30896= NG_029791.1:g.30896T>G
TNFRSF1B transcript NM_001066.3:c.587= NM_001066.3:c.587T>G
TNFRSF1B transcript NM_001066.2:c.587= NM_001066.2:c.587T>G
TNFRSF1B transcript variant X1 XM_011542060.3:c.587= XM_011542060.3:c.587T>G
TNFRSF1B transcript variant X2 XM_011542060.2:c.587= XM_011542060.2:c.587T>G
TNFRSF1B transcript variant X1 XM_011542060.1:c.587= XM_011542060.1:c.587T>G
TNFRSF1B transcript variant X4 XM_011542063.3:c.587= XM_011542063.3:c.587T>G
TNFRSF1B transcript variant X3 XM_011542063.2:c.587= XM_011542063.2:c.587T>G
TNFRSF1B transcript variant X4 XM_011542063.1:c.587= XM_011542063.1:c.587T>G
TNFRSF1B transcript variant X5 XM_047429424.1:c.434= XM_047429424.1:c.434T>G
TNFRSF1B transcript variant X3 XM_047429423.1:c.566= XM_047429423.1:c.566T>G
TNFRSF1B transcript variant X2 XM_047429422.1:c.587= XM_047429422.1:c.587T>G
tumor necrosis factor receptor superfamily member 1B precursor NP_001057.1:p.Met196= NP_001057.1:p.Met196Arg
tumor necrosis factor receptor superfamily member 1B isoform X1 XP_011540362.1:p.Met196= XP_011540362.1:p.Met196Arg
tumor necrosis factor receptor superfamily member 1B isoform X4 XP_011540365.1:p.Met196= XP_011540365.1:p.Met196Arg
tumor necrosis factor receptor superfamily member 1B isoform X5 XP_047285380.1:p.Met145= XP_047285380.1:p.Met145Arg
tumor necrosis factor receptor superfamily member 1B isoform X3 XP_047285379.1:p.Met189= XP_047285379.1:p.Met189Arg
tumor necrosis factor receptor superfamily member 1B isoform X2 XP_047285378.1:p.Met196= XP_047285378.1:p.Met196Arg
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

178 SubSNP, 30 Frequency, 2 ClinVar submissions
No Submitter Submission ID Date (Build)
1 SC_JCM ss2510856 Nov 09, 2000 (96)
2 WIAF-CSNP ss3173181 Aug 15, 2001 (102)
3 HGBASE ss3182272 Aug 15, 2001 (98)
4 EGP_SNPS ss7990727 Apr 21, 2003 (114)
5 CUORCGL ss12568611 Aug 26, 2003 (117)
6 IMCJ-GDT ss22887876 Apr 05, 2004 (123)
7 PERLEGEN ss23845243 Sep 20, 2004 (123)
8 PGA-UW-FHCRC ss28528913 Dec 02, 2004 (126)
9 APPLERA_GI ss48421604 Mar 10, 2006 (126)
10 PGA-UW-FHCRC ss52088967 Oct 13, 2006 (127)
11 ILLUMINA ss65724812 Oct 13, 2006 (127)
12 KRIBB_YJKIM ss65836872 Nov 29, 2006 (127)
13 ILLUMINA ss66666521 Nov 29, 2006 (127)
14 EGP_SNPS ss66857595 Nov 29, 2006 (127)
15 ILLUMINA ss66896589 Nov 29, 2006 (127)
16 ILLUMINA ss67006743 Nov 29, 2006 (127)
17 PERLEGEN ss68758710 May 16, 2007 (127)
18 ILLUMINA ss70377142 May 16, 2007 (127)
19 ILLUMINA ss70492642 May 25, 2008 (130)
20 ILLUMINA ss71017335 May 16, 2007 (127)
21 AFFY ss74811944 Aug 16, 2007 (128)
22 ILLUMINA ss75726432 Dec 06, 2007 (129)
23 CGM_KYOTO ss76870039 Dec 06, 2007 (129)
24 HGSV ss80885031 Dec 15, 2007 (130)
25 KRIBB_YJKIM ss83676225 Dec 15, 2007 (130)
26 CANCER-GENOME ss86341825 Mar 23, 2008 (129)
27 1000GENOMES ss107996605 Jan 22, 2009 (130)
28 1000GENOMES ss110065962 Jan 24, 2009 (130)
29 ILLUMINA-UK ss118501986 Feb 14, 2009 (130)
30 ILLUMINA ss120035931 Dec 01, 2009 (131)
31 ILLUMINA ss121373522 Dec 01, 2009 (131)
32 ILLUMINA ss152797129 Dec 01, 2009 (131)
33 ILLUMINA ss159137474 Dec 01, 2009 (131)
34 SEATTLESEQ ss159696121 Dec 01, 2009 (131)
35 ILLUMINA ss159911628 Dec 01, 2009 (131)
36 COMPLETE_GENOMICS ss163082387 Jul 04, 2010 (132)
37 COMPLETE_GENOMICS ss163838614 Jul 04, 2010 (132)
38 ILLUMINA ss169574283 Jul 04, 2010 (132)
39 ILLUMINA ss170399408 Jul 04, 2010 (132)
40 BUSHMAN ss198030314 Jul 04, 2010 (132)
41 1000GENOMES ss218240051 Jul 14, 2010 (132)
42 1000GENOMES ss230428826 Jul 14, 2010 (132)
43 1000GENOMES ss238143835 Jul 15, 2010 (132)
44 ILLUMINA ss244269725 Jul 04, 2010 (132)
45 BL ss252920300 May 09, 2011 (134)
46 GMI ss275716410 May 04, 2012 (137)
47 NHLBI-ESP ss341933995 May 09, 2011 (134)
48 ILLUMINA ss479321523 May 04, 2012 (137)
49 ILLUMINA ss479324713 May 04, 2012 (137)
50 ILLUMINA ss479712401 Sep 08, 2015 (146)
51 ILLUMINA ss484461056 May 04, 2012 (137)
52 1000GENOMES ss489721546 May 04, 2012 (137)
53 EXOME_CHIP ss491286397 May 04, 2012 (137)
54 CLINSEQ_SNP ss491584774 May 04, 2012 (137)
55 ILLUMINA ss536625169 Sep 08, 2015 (146)
56 TISHKOFF ss553804952 Apr 25, 2013 (138)
57 SSMP ss647580139 Apr 25, 2013 (138)
58 ILLUMINA ss778361807 Aug 21, 2014 (142)
59 ILLUMINA ss780763980 Aug 21, 2014 (142)
60 ILLUMINA ss782677088 Aug 21, 2014 (142)
61 ILLUMINA ss783443155 Aug 21, 2014 (142)
62 ILLUMINA ss783645676 Aug 21, 2014 (142)
63 ILLUMINA ss825346753 Apr 01, 2015 (144)
64 ILLUMINA ss831927833 Apr 01, 2015 (144)
65 ILLUMINA ss832650134 Aug 21, 2014 (142)
66 ILLUMINA ss833240823 Aug 21, 2014 (142)
67 ILLUMINA ss833816588 Aug 21, 2014 (142)
68 JMKIDD_LAB ss974433282 Aug 21, 2014 (142)
69 EVA-GONL ss974863387 Aug 21, 2014 (142)
70 JMKIDD_LAB ss1067416294 Aug 21, 2014 (142)
71 JMKIDD_LAB ss1067675021 Aug 21, 2014 (142)
72 1000GENOMES ss1289714033 Aug 21, 2014 (142)
73 DDI ss1425714675 Apr 01, 2015 (144)
74 EVA_GENOME_DK ss1573891240 Apr 01, 2015 (144)
75 EVA_FINRISK ss1584004755 Apr 01, 2015 (144)
76 EVA_DECODE ss1584221428 Apr 01, 2015 (144)
77 EVA_UK10K_ALSPAC ss1599563907 Apr 01, 2015 (144)
78 EVA_UK10K_TWINSUK ss1642557940 Apr 01, 2015 (144)
79 EVA_EXAC ss1685309303 Apr 01, 2015 (144)
80 EVA_MGP ss1710888722 Apr 01, 2015 (144)
81 EVA_SVP ss1712311709 Apr 01, 2015 (144)
82 ILLUMINA ss1751867515 Sep 08, 2015 (146)
83 HAMMER_LAB ss1793916180 Sep 08, 2015 (146)
84 WEILL_CORNELL_DGM ss1918063495 Feb 12, 2016 (147)
85 ILLUMINA ss1958242109 Feb 12, 2016 (147)
86 JJLAB ss2019545589 Sep 14, 2016 (149)
87 ILLUMINA ss2094953256 Dec 20, 2016 (150)
88 USC_VALOUEV ss2147544001 Dec 20, 2016 (150)
89 HUMAN_LONGEVITY ss2160112160 Dec 20, 2016 (150)
90 ILLUMINA ss2632478497 Nov 08, 2017 (151)
91 GRF ss2697440793 Nov 08, 2017 (151)
92 GNOMAD ss2731129128 Nov 08, 2017 (151)
93 GNOMAD ss2746218113 Nov 08, 2017 (151)
94 GNOMAD ss2751709562 Nov 08, 2017 (151)
95 AFFY ss2984845574 Nov 08, 2017 (151)
96 SWEGEN ss2986308731 Nov 08, 2017 (151)
97 ILLUMINA ss3021055208 Nov 08, 2017 (151)
98 BIOINF_KMB_FNS_UNIBA ss3023537022 Nov 08, 2017 (151)
99 CSHL ss3343321188 Nov 08, 2017 (151)
100 ILLUMINA ss3626027995 Oct 11, 2018 (152)
101 ILLUMINA ss3626027996 Oct 11, 2018 (152)
102 ILLUMINA ss3630516820 Oct 11, 2018 (152)
103 ILLUMINA ss3632881061 Oct 11, 2018 (152)
104 ILLUMINA ss3633574912 Oct 11, 2018 (152)
105 ILLUMINA ss3634307315 Oct 11, 2018 (152)
106 ILLUMINA ss3634307316 Oct 11, 2018 (152)
107 ILLUMINA ss3635269032 Oct 11, 2018 (152)
108 ILLUMINA ss3635983520 Oct 11, 2018 (152)
109 ILLUMINA ss3637019399 Oct 11, 2018 (152)
110 ILLUMINA ss3637737899 Oct 11, 2018 (152)
111 ILLUMINA ss3638890117 Oct 11, 2018 (152)
112 ILLUMINA ss3639441955 Oct 11, 2018 (152)
113 ILLUMINA ss3640014679 Oct 11, 2018 (152)
114 ILLUMINA ss3640014680 Oct 11, 2018 (152)
115 ILLUMINA ss3640975004 Oct 11, 2018 (152)
116 ILLUMINA ss3641268855 Oct 11, 2018 (152)
117 ILLUMINA ss3642751647 Oct 11, 2018 (152)
118 ILLUMINA ss3644480771 Oct 11, 2018 (152)
119 OMUKHERJEE_ADBS ss3646221551 Oct 11, 2018 (152)
120 ILLUMINA ss3651379287 Oct 11, 2018 (152)
121 ILLUMINA ss3651379288 Oct 11, 2018 (152)
122 ILLUMINA ss3653619219 Oct 11, 2018 (152)
123 EGCUT_WGS ss3654409550 Jul 12, 2019 (153)
124 EVA_DECODE ss3686179619 Jul 12, 2019 (153)
125 ILLUMINA ss3724997193 Jul 12, 2019 (153)
126 ACPOP ss3726797155 Jul 12, 2019 (153)
127 ILLUMINA ss3744608296 Jul 12, 2019 (153)
128 ILLUMINA ss3744608297 Jul 12, 2019 (153)
129 EVA ss3745839061 Jul 12, 2019 (153)
130 PAGE_CC ss3770786137 Jul 12, 2019 (153)
131 ILLUMINA ss3772109904 Jul 12, 2019 (153)
132 KHV_HUMAN_GENOMES ss3798859607 Jul 12, 2019 (153)
133 EVA ss3823561438 Apr 25, 2020 (154)
134 EVA ss3825553787 Apr 25, 2020 (154)
135 EVA ss3826027264 Apr 25, 2020 (154)
136 EVA ss3836400497 Apr 25, 2020 (154)
137 EVA ss3841804678 Apr 25, 2020 (154)
138 HGDP ss3847324703 Apr 25, 2020 (154)
139 SGDP_PRJ ss3848210340 Apr 25, 2020 (154)
140 KRGDB ss3893096864 Apr 25, 2020 (154)
141 KOGIC ss3943842757 Apr 25, 2020 (154)
142 FSA-LAB ss3983916446 Apr 25, 2021 (155)
143 FSA-LAB ss3983916447 Apr 25, 2021 (155)
144 EVA ss3984447013 Apr 25, 2021 (155)
145 EVA ss3984452284 Apr 25, 2021 (155)
146 EVA ss3984778957 Apr 25, 2021 (155)
147 EVA ss3986008537 Apr 25, 2021 (155)
148 EVA ss3986099575 Apr 25, 2021 (155)
149 EVA ss4016893784 Apr 25, 2021 (155)
150 TOPMED ss4439478604 Apr 25, 2021 (155)
151 TOMMO_GENOMICS ss5142513196 Apr 25, 2021 (155)
152 EVA ss5236864381 Apr 25, 2021 (155)
153 EVA ss5237260153 Apr 25, 2021 (155)
154 EVA ss5237630976 Oct 12, 2022 (156)
155 1000G_HIGH_COVERAGE ss5241204971 Oct 12, 2022 (156)
156 TRAN_CS_UWATERLOO ss5314394567 Oct 12, 2022 (156)
157 EVA ss5314593592 Oct 12, 2022 (156)
158 EVA ss5316801520 Oct 12, 2022 (156)
159 HUGCELL_USP ss5442406117 Oct 12, 2022 (156)
160 1000G_HIGH_COVERAGE ss5512975190 Oct 12, 2022 (156)
161 EVA ss5623987572 Oct 12, 2022 (156)
162 SANFORD_IMAGENETICS ss5624196714 Oct 12, 2022 (156)
163 SANFORD_IMAGENETICS ss5624940979 Oct 12, 2022 (156)
164 TOMMO_GENOMICS ss5666827727 Oct 12, 2022 (156)
165 EVA ss5799407254 Oct 12, 2022 (156)
166 EVA ss5799475295 Oct 12, 2022 (156)
167 EVA ss5800045443 Oct 12, 2022 (156)
168 EVA ss5800077935 Oct 12, 2022 (156)
169 YY_MCH ss5800330068 Oct 12, 2022 (156)
170 EVA ss5831550901 Oct 12, 2022 (156)
171 EVA ss5847152763 Oct 12, 2022 (156)
172 EVA ss5847525802 Oct 12, 2022 (156)
173 EVA ss5848248377 Oct 12, 2022 (156)
174 EVA ss5848787212 Oct 12, 2022 (156)
175 EVA ss5907075839 Oct 12, 2022 (156)
176 EVA ss5936767765 Oct 12, 2022 (156)
177 EVA ss5979263270 Oct 12, 2022 (156)
178 EVA ss5979933929 Oct 12, 2022 (156)
179 1000Genomes NC_000001.10 - 12252955 Oct 11, 2018 (152)
180 1000Genomes_30x NC_000001.11 - 12192898 Oct 12, 2022 (156)
181 The Avon Longitudinal Study of Parents and Children NC_000001.10 - 12252955 Oct 11, 2018 (152)
182 Genetic variation in the Estonian population NC_000001.10 - 12252955 Oct 11, 2018 (152)
183 ExAC NC_000001.10 - 12252955 Oct 11, 2018 (152)
184 FINRISK NC_000001.10 - 12252955 Apr 25, 2020 (154)
185 The Danish reference pan genome NC_000001.10 - 12252955 Apr 25, 2020 (154)
186 gnomAD - Genomes NC_000001.11 - 12192898 Apr 25, 2021 (155)
187 gnomAD - Exomes NC_000001.10 - 12252955 Jul 12, 2019 (153)
188 GO Exome Sequencing Project NC_000001.10 - 12252955 Oct 11, 2018 (152)
189 Genome of the Netherlands Release 5 NC_000001.10 - 12252955 Apr 25, 2020 (154)
190 HGDP-CEPH-db Supplement 1 NC_000001.9 - 12175542 Apr 25, 2020 (154)
191 HapMap NC_000001.11 - 12192898 Apr 25, 2020 (154)
192 KOREAN population from KRGDB NC_000001.10 - 12252955 Apr 25, 2020 (154)
193 Korean Genome Project NC_000001.11 - 12192898 Apr 25, 2020 (154)
194 Medical Genome Project healthy controls from Spanish population NC_000001.10 - 12252955 Apr 25, 2020 (154)
195 Northern Sweden NC_000001.10 - 12252955 Jul 12, 2019 (153)
196 The PAGE Study NC_000001.11 - 12192898 Jul 12, 2019 (153)
197 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000001.10 - 12252955 Apr 25, 2021 (155)
198 CNV burdens in cranial meningiomas NC_000001.10 - 12252955 Apr 25, 2021 (155)
199 MxGDAR/Encodat-PGx NC_000001.10 - 12252955 Apr 25, 2021 (155)
200 Qatari NC_000001.10 - 12252955 Apr 25, 2020 (154)
201 SGDP_PRJ NC_000001.10 - 12252955 Apr 25, 2020 (154)
202 Siberian NC_000001.10 - 12252955 Apr 25, 2020 (154)
203 8.3KJPN NC_000001.10 - 12252955 Apr 25, 2021 (155)
204 14KJPN NC_000001.11 - 12192898 Oct 12, 2022 (156)
205 TopMed NC_000001.11 - 12192898 Apr 25, 2021 (155)
206 UK 10K study - Twins NC_000001.10 - 12252955 Oct 11, 2018 (152)
207 A Vietnamese Genetic Variation Database NC_000001.10 - 12252955 Jul 12, 2019 (153)
208 ALFA NC_000001.11 - 12192898 Apr 25, 2021 (155)
209 ClinVar RCV001354054.1 Oct 12, 2022 (156)
210 ClinVar RCV001836993.1 Oct 12, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs1681698 Jun 15, 2001 (96)
rs2228492 Jan 04, 2002 (102)
rs13306722 Sep 24, 2004 (123)
rs17037789 Oct 07, 2004 (123)
rs17883437 Mar 10, 2006 (126)
rs52797629 Sep 21, 2007 (128)
rs60195947 May 25, 2008 (130)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss80885031, ss3638890117, ss3639441955 NC_000001.8:12187220:T:G NC_000001.11:12192897:T:G (self)
2595, ss107996605, ss110065962, ss118501986, ss159911628, ss163082387, ss163838614, ss198030314, ss244269725, ss252920300, ss275716410, ss479321523, ss491584774, ss825346753, ss1584221428, ss1712311709, ss3642751647, ss3847324703 NC_000001.9:12175541:T:G NC_000001.11:12192897:T:G (self)
391214, 204136, 147798, 4489062, 1216, 1392171, 145713, 20163, 86922, 274258, 5474, 82020, 4884, 1585, 14, 105425, 227320, 60355, 482503, 204136, 42696, ss218240051, ss230428826, ss238143835, ss341933995, ss479324713, ss479712401, ss484461056, ss489721546, ss491286397, ss536625169, ss553804952, ss647580139, ss778361807, ss780763980, ss782677088, ss783443155, ss783645676, ss831927833, ss832650134, ss833240823, ss833816588, ss974433282, ss974863387, ss1067416294, ss1067675021, ss1289714033, ss1425714675, ss1573891240, ss1584004755, ss1599563907, ss1642557940, ss1685309303, ss1710888722, ss1751867515, ss1793916180, ss1918063495, ss1958242109, ss2019545589, ss2094953256, ss2147544001, ss2632478497, ss2697440793, ss2731129128, ss2746218113, ss2751709562, ss2984845574, ss2986308731, ss3021055208, ss3343321188, ss3626027995, ss3626027996, ss3630516820, ss3632881061, ss3633574912, ss3634307315, ss3634307316, ss3635269032, ss3635983520, ss3637019399, ss3637737899, ss3640014679, ss3640014680, ss3640975004, ss3641268855, ss3644480771, ss3646221551, ss3651379287, ss3651379288, ss3653619219, ss3654409550, ss3726797155, ss3744608296, ss3744608297, ss3745839061, ss3772109904, ss3823561438, ss3825553787, ss3826027264, ss3836400497, ss3848210340, ss3893096864, ss3983916446, ss3983916447, ss3984447013, ss3984452284, ss3984778957, ss3986008537, ss3986099575, ss4016893784, ss5142513196, ss5237260153, ss5314593592, ss5316801520, ss5623987572, ss5624196714, ss5624940979, ss5799407254, ss5799475295, ss5800045443, ss5800077935, ss5831550901, ss5847152763, ss5847525802, ss5848248377, ss5936767765, ss5979263270, ss5979933929 NC_000001.10:12252954:T:G NC_000001.11:12192897:T:G (self)
RCV001354054.1, RCV001836993.1, 501125, 2718234, 14685, 220758, 7606, 664831, 3084939, 5252962578, ss2160112160, ss3023537022, ss3686179619, ss3724997193, ss3770786137, ss3798859607, ss3841804678, ss3943842757, ss4439478604, ss5236864381, ss5237630976, ss5241204971, ss5314394567, ss5442406117, ss5512975190, ss5666827727, ss5800330068, ss5848787212, ss5907075839 NC_000001.11:12192897:T:G NC_000001.11:12192897:T:G (self)
ss2510856, ss3173181, ss3182272, ss7990727, ss12568611, ss22887876, ss23845243, ss28528913, ss48421604, ss52088967, ss65724812, ss65836872, ss66666521, ss66857595, ss66896589, ss67006743, ss68758710, ss70377142, ss70492642, ss71017335, ss74811944, ss75726432, ss76870039, ss83676225, ss86341825, ss120035931, ss121373522, ss152797129, ss159137474, ss159696121, ss169574283, ss170399408 NT_021937.19:8257686:T:G NC_000001.11:12192897:T:G (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

60 citations for rs1061622
PMID Title Author Year Journal
15113403 Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis. Dvornyk V et al. 2004 BMC genetics
16109524 Preparation and analysis of cSNP chip on hepatocellular carcinoma-related genes. Wang J et al. 2005 Hepatobiliary & pancreatic diseases international
16380915 Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Plenge RM et al. 2005 American journal of human genetics
17705862 Optimization of candidate-gene SNP-genotyping by flexible oligonucleotide microarrays; analyzing variations in immune regulator genes of hay-fever samples. Pullat J et al. 2007 BMC genomics
18248655 Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn's disease. Matsukura H et al. 2008 Alimentary pharmacology & therapeutics
18385279 The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis. Toonen EJ et al. 2008 Annals of the rheumatic diseases
18466472 Constructing gene association networks for rheumatoid arthritis using the backward genotype-trait association (BGTA) algorithm. Ding Y et al. 2007 BMC proceedings
18466513 Evaluating gene x gene and gene x smoking interaction in rheumatoid arthritis using candidate genes in GAW15. Mei L et al. 2007 BMC proceedings
18603647 Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Simoni M et al. 2008 Human reproduction update
18805939 Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Tempfer CB et al. 2009 Human reproduction update
19343543 Association analysis of TNFRSF1B polymorphisms with type 2 diabetes and its related traits in North India. Tabassum R et al. 2008 Genomic medicine
19401444 Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Martínez-García MA et al. 2009 Diabetes care
19421420 Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand caucasian population. Ferguson LR et al. 2009 Gastroenterology research and practice
19684152 Cigarette smoking, STAT4 and TNFRSF1B polymorphisms, and systemic lupus erythematosus in a Japanese population. Kiyohara C et al. 2009 The Journal of rheumatology
19773451 Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Reyes-Gibby CC et al. 2009 Cancer epidemiology, biomarkers & prevention
20007930 A functional haplotype in the 3'untranslated region of TNFRSF1B is associated with tuberculosis in two African populations. Möller M et al. 2010 American journal of respiratory and critical care medicine
20018049 Evaluation of an optimal receiver operating characteristic procedure. Jeffries N et al. 2009 BMC proceedings
20309765 Bagging optimal ROC curve method for predictive genetic tests, with an application for rheumatoid arthritis. Lu Q et al. 2010 Journal of biopharmaceutical statistics
20357209 Molecular genetic studies of gene identification for osteoporosis: the 2009 update. Xu XH et al. 2010 Endocrine reviews
20646319 TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. Kuwahara A et al. 2010 Journal of experimental & clinical cancer research
20811626 Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Hildebrandt MA et al. 2010 PloS one
21760883 Genetic determinants of UV-susceptibility in non-melanoma skin cancer. Welsh MM et al. 2011 PloS one
21776368 Association of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymorphisms with Ischemic Stroke in a Greek Population. Markoula S et al. 2011 Stroke research and treatment
21849023 No association of TNFRSF1B variants with type 2 diabetes in Indians of Indo-European origin. Tabassum R et al. 2011 BMC medical genetics
21995493 TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy. Guan X et al. 2011 BMC cancer
22860894 Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease. Steenholdt C et al. 2012 Alimentary pharmacology & therapeutics
22921902 The methionine 196 arginine polymorphism of the TNF receptor 2 gene (TNFRSF1B) is not associated with worse outcomes in heart failure. McTiernan CF et al. 2012 Cytokine
22984424 Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis. Schiotis R et al. 2012 PloS one
23029405 Genetic variation in the TNF gene is associated with susceptibility to severe sepsis, but not with mortality. Song Z et al. 2012 PloS one
23238918 Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis. Song GG et al. 2013 Molecular biology reports
23422753 Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Flanagan JM et al. 2013 Blood
23720679 Prognostic assessment of apoptotic gene polymorphisms in non-small cell lung cancer in Chinese. Cao S et al. 2013 Journal of biomedical research
23799986 Maternal tumor necrosis factor receptor 2 gene variants associated with pre-eclampsia in Tunisian women. Said L et al. 2013 The journal of obstetrics and gynaecology research
23839018 TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer. Schabath MB et al. 2013 Carcinogenesis
24069534 Genetics of psoriasis and pharmacogenetics of biological drugs. Prieto-Pérez R et al. 2013 Autoimmune diseases
24121042 Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab. Medrano LM et al. 2014 Human immunology
24337767 Candidate's single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitis. Schiotis R et al. 2014 Rheumatology international
25010932 Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women. Xu F et al. 2014 PloS one
25075970 The associations between immunity-related genes and breast cancer prognosis in Korean women. Choi J et al. 2014 PloS one
25537528 The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients. González-Lara L et al. 2015 Archives of dermatological research
26071216 The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis. Chen W et al. 2015 International immunopharmacology
26861312 Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease. Prieto-Pérez R et al. 2016 International journal of molecular sciences
26870349 Impact of single-nucleotide polymorphisms on radiation pneumonitis in cancer patients. Guo CX et al. 2016 Molecular and clinical oncology
27247849 Genetic variation and cognitive dysfunction in opioid-treated patients with cancer. Kurita GP et al. 2016 Brain and behavior
27417569 Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases. Bek S et al. 2016 Alimentary pharmacology & therapeutics
27555379 Genetic Contributions of Inflammation to Depression. Barnes J et al. 2017 Neuropsychopharmacology
27640805 Association of TNFRSF1B +676 gene polymorphism with the risk of rheumatoid arthritis in Han Chinese population in Hunan. Xie X et al. 2016 Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
28750567 Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis. Murdaca G et al. 2017 Expert opinion on drug safety
28867280 Interaction between childhood maltreatment on immunogenetic risk in depression: Discovery and replication in clinical case-control samples. Cohen-Woods S et al. 2018 Brain, behavior, and immunity
29285231 Associations between TNFSF4, TNFSF8 and TNFSF15 and Behçet's disease but not VKH syndrome in Han Chinese. Jiang Y et al. 2017 Oncotarget
29799484 Reduced Recovery of Depression in Female T Allele Carriers of TNF-RII rs1061622 at Earlier Stage after Wenchuan Earthquake. Memon NH et al. 2018 International journal of environmental research and public health
29915336 The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population. Ma L et al. 2018 Scientific reports
30075559 Role of TNFRSF1A and TNFRSF1B polymorphisms in susceptibility, severity, and therapeutic efficacy of etanercept in human leukocyte antigen-B27-positive Chinese Han patients with ankylosing spondylitis. Xing-Rong W et al. 2018 Medicine
30206443 Genetic polymorphism in psoriasis and its meaning for the treatment efficacy in the future. Osmola-Mańkowska A et al. 2018 Postepy dermatologii i alergologii
30472484 TNFα -857 C/T and TNFR2 +587 T/G polymorphisms are associated with cystic fibrosis in Iranian patients. Hassanzad M et al. 2019 European journal of medical genetics
31734995 [Study of tumor necrosis factor receptor superfamily 1B gene polymorphism in relation to the outcomes of HCV infection]. Zhu P et al. 2019 Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
32559305 Increased TG/HDL-C in female G allele carriers of rs1061622 at gene of tumour necrosis factor receptor 2 with suicidal ideation. Si YJ et al. 2020 European journal of clinical investigation
33716716 TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease. Pillai JA et al. 2021 Frontiers in aging neuroscience
35294530 TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19. Fricke-Galindo I et al. 2022 The Journal of infectious diseases
35629038 Searching for New Genetic Biomarkers of Axial Spondyloarthritis. Bugaj B et al. 2022 Journal of clinical medicine
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post761+d5e8e07